Abstract
Introduction
Pagetoid reticulosis (PR) is a rare variant of mycosis fungoides, characterized by localized patches or plaques mainly on the distal extremities with intraepidermal proliferation of neoplastic T cells. Typically, PR exhibits a CD4-positive, CD8-negative immunophenotype, whereas a CD4–/CD8– double-negative profile is distinctly uncommon, yet in localized pagetoid reticulosis it may be associated with an indolent clinical course and favorable therapeutic response.
Case Presentation
In this report, we present a case of a healthy 58-year-old male with a 3-year history of a persistent erythematous plaque on the left forearm. Histopathological analysis demonstrated atypical lymphocytes with prominent epidermotropism. Immunohistochemical staining showed double-negative CD4/CD8 phenotype with positive CD3, CD5, and CD7. The lesion responded completely to topical therapy followed by localized radiotherapy, with clinical remission at follow-up.
Conclusion
The CD4−/CD8− immunophenotype in localized pagetoid reticulosis is rare but may still be associated with an indolent clinical course and favorable therapeutic response.
Keywords: Pagetoid reticulosis, Double negative immunophenotype CD4/CD8, Mycosis fungoides, Cutaneous T-cell lymphoma
Introduction
Woringer-Kolopp disease, also known as localized pagetoid reticulosis (PR), is a primary cutaneous T-cell lymphoma categorized as an indolent localized variant of mycosis fungoides. Clinically, it presents as solitary, slowly progressive psoriasiform or hyperkeratotic patches or plaques, typically localized to the upper or lower extremity. Histologically, PR is characterized by a hyperplastic epidermis with atypical neoplastic T cells arranged in a pagetoid pattern. The immunophenotype of these cells can include CD3+, CD4+, CD8- or CD3+, CD4−, CD8+ phenotypes, with the double-negative CD4−/CD8− phenotype being exceptionally rare, Preferred treatments for PR include radiotherapy or surgical excision, with topical therapies as viable alternatives [1]. In this case report, we describe a rare instance of double-negative CD4− and CD8− PR successfully treated with topicals and radiotherapy.
Case Presentation
A 58-year-old male presented to our clinic with a 3-year history of asymptomatic, solitary, and slowly progressing 10 × 7 cm erythematous to lightly violaceous plaque, irregular, raised, and well-defined brownish borders on the left ventral forearm (Fig. 1a). Despite multiple treatments with over-the-counter medications with topical antifungals for a presumed dermatophyte infection, the lesion persisted and exhibited slight enlargement. The patient’s medical background is significant for treated rectal cancer with abdominoperineal resection in 2019, followed by adjuvant therapy with complete remission at the time of the presentation, diabetes mellitus, and hypertension. Physical examination was negative for lymphadenopathy. Potassium hydroxide preparation and fungal culture yielded negative results. A 3-mm skin punch biopsy was performed for pathological examination, revealing mild epidermal hyperplasia with prominent epidermotropism, small microabscesses, and atypical lymphocytic infiltrate in the superficial dermis. The lymphocytes exhibited large, convoluted nuclei with hyperchromasia, and a less prominent focal dermal fibrosis also was noted (Fig. 2). Immunophenotyping of lymphocytes was represented (CD5/CD3/CD7 positive; CD4/CD8 negative) (Fig. 2b) (Fig. 3 c, d).
Fig. 1.

a Hyperpigmented well defined scaly plaque over the left forearm (before treatment). b 6 months after the last radiation session showing complete resolution with residual post-inflammatory hyperpigmentation.
Fig. 2.

a Epidermotropic infiltrate of atypical lymphocytes at basal epidermis with upward scatter in the upper dermis accompanied by acanthosis and parakeratosis hematoxylin and eosin stain (H&E; ×100 magnification). b Immunohistochemistry for CD3 highlighting the T-cell nature of the infiltrating cells (×100 magnification).
Fig. 3.

a, b Immunohistochemical staining for CD4 and CD8, respectively, showing double negativity in the PR cells (×200 magnification).
Based on the clinicopathological correlation, a diagnosis of PR was made with CD4/CD8 double-negative immunophenotype. A clonal T-cell population was detected by TCR rearrangement test using TCR-γ gene was amplified and PCR products were identified using capillary electrophoresis with an ABI prime 3,500 gene analyzer.
The patient was treated initially with topical clobetasol propionate 0.05% twice daily for 4 weeks followed by radiation therapy at 300 cGy in 10 fractions with an accumulated total dose of 3,000 cGy using 2 field AP-PA technique. 4 weeks after the last radiation session, the plaques resolved with only residual post inflammatory hyperpigmentation. 6 month follow up, the patient has been disease-free since the therapy was initiated (Fig. 1b).
The CARE Checklist has been completed by the authors for this case report and is attached as online supplementary material (for all online suppl. material, see https://doi.org/10.1159/000551216).
Discussion
This report details a rare case presentation of localized PR characterized by a double-negative CD4−/CD8− immunophenotype with TCRγ clonality. PR is a subtype of cutaneous T-cell lymphoma with unique histopathologic features that are strictly confined to the epidermis and a distinctive variable nature of CD marker expression properties [1].
Histologically, our case revealed a pronounced epidermotropism consistent with the finding in Osto et al. which identified 143 histologically confirmed PR. Although a minimal upper dermal infiltration is occasionally described only in 20.6% of the cases in review [2]. Our case distinctly demonstrated superficial dermis involvement by neoplastic T cells, which is a further distinguished feature.
In addition, immunophenotyping demonstrated a double-negative CD4−/CD8− profile. A phenotype observed in only 13.1% of cases reviewed by Osto et al. [2] and in 11% of cases reviewed by Mourtzinos et al. [3] This contrasts with the prevalent phenotypes of CD4−/CD8+ (48.8%), CD4+/CD8+ (20.2%), or CD4+/CD8− (17.9%) [3].
The preservation of CD3, CD5, and CD7 in our patient, whereas most cutaneous T-cell lymphomas including PR, commonly show a loss of CD7 [1, 2]. Alongside the double-negative profile, underscores the unique nature of this case and its contribution to the understanding of PRs immunophenotypic diversity.
The expression of TCRγ in our patient adds more complexity to the case. Studies conducted by Alaibac and Chu et al. [4] suggest that TCRγ/δ+ T-cells may play a role in the pathogenesis of PR, proposing that some double-negative PR cases might represent indolent γδ T-cell lymphomas [4]. This aligns with our findings, indicating that CD4/CD8 double-negative PR cases could originate from cells expressing TCRγδ. In contrast, the Mountains et al. review has linked CD4/CD8 double-negative to worse prognosis because it is associated with a higher proliferation index in relation to other CD expressions [3].
Jones et al. [5] concluded that TCR gamma/delta expression in non-MF CTCL is characterized by aggressive behavior and increased risk for rapid skin dissemination. However, our case showed an indolent clinical course with a dramatic response to treatment. This supports that double negative CD4/CD8 appears to lack prognostic significance in localized PR [5]. Similar benign clinical behavior exhibited in early MF with CD4/CD8 double negative phenotype [6].
The therapeutic approaches for PR are varied and driven mostly by anecdotal case reports and case series. Radiation, topical corticosteroids, nitrogen mustard, systemic chemotherapy, and phototherapy, all tried with various success rates. However, radiotherapy found to be the most favored due to its efficacy in inducing remission. A near complete-to-complete resolution after treatment reaches up to 81%, and monotherapy appears to be preferred for solitary small lesions [2, 3]. Lee et al. [7] identified radiation therapy as the most effective treatment in adults as evident from our case [7].
Our patient was treated with localized radiation therapy (3,000 cGy in 10 fractions) combined with topical potent steroids, resulting in complete resolution of plaques and sustained remission. In comparison, Wood et al. [8] reported a case of PR with a double-negative CD4/CD8 phenotype treated with radiotherapy (2000 cGy), achieving a complete clinical response within 1 month [8].
Mourtzinos et al. [3] described a case of PR with a double-negative CD4/CD8 phenotype treated with local radiation therapy at 200 cGy for 15 sessions, with a total dose of 3,000 cGy, followed by 6 months of nitrogen mustard. The patient experienced complete resolution of plaques and has remained disease-free for 33 months since the therapy was initiated [3]. Lastly, Zengin et al. [9] described a PR case co-expressing CD4 and CD8, treated with electron-beam radiotherapy (36.4 Gy in 13 fractions), resulting in complete resolution and no recurrence after 38 months [9]. Despite the rarity of the disease and the limited treatment options for PR, radiotherapy consistently induces remission across the reported cases in the literature, highlighting its efficacy as one of the therapeutic options for PR.
Conclusion
Double-negative CD4/CD8 PR phenotype is rare and often presents in an atypical presentation. In localized disease, this immunophenotype may still be associated with a favorable outcome. In most PR cases, there is a complete or partial loss of CD7, while CD3, CD2, and CD5 are typically preserved. Few treatment options are available based on anecdotal cases in the literature; localized radiotherapy shows promise for inducing remission.
Statement of Ethics
This study protocol was reviewed, and the need for approval was waived by the Research Ethics Committee of King Faisal Specialist Hospital and Research Centre, Jeddah, Saudi Arabia. Written informed consent was obtained from the patient for publication of the details of their medical case and any accompanying images. The patient was informed that all identifying information would remain confidential and that participation was voluntary. Consent for the publication of recognizable patient photographs or other identifiable material was obtained by the authors and included at the time of article submission to the journal stating that all patients gave consent with the understanding that this information may be publicly available.
Conflict of Interest Statement
The authors declare no conflict of interest.
Funding Sources
No external funding was received for this study.
Author Contributions
Ghassan Niaz, MD, FAAD: conceptualization, supervision, and writing – review and editing. Hadeel Alsulimani, MBBS, Hamza A. Fadel, MBBS, Amal A. Alomari, MBBS, and Hosam Alardati, MD: conceptualization, investigation, data curation, and writing – original draft.
Funding Statement
No external funding was received for this study.
Data Availability Statement
The data supporting this case report are published online and available for reference. Further inquiries can be directed to the corresponding author, Dr. Ghassan Niaz.
Supplementary Material.
References
- 1. Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019;133(16):1703–14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Osto M, Afify O, Musa A, Ahmed U, Rehman R, Mehregan D. Woringer-Kolopp disease (localized pagetoid reticulosis): a systematic review. Int J Dermatol. 2023;62(3):312–21. [DOI] [PubMed] [Google Scholar]
- 3. Mourtzinos N, Puri PK, Wang G, Liu ML. CD4/CD8 double negative pagetoid reticulosis: a case report and literature review. J Cutan Pathol. 2010;37(4):491–6. [DOI] [PubMed] [Google Scholar]
- 4. Alaibac M, Chu A. Pagetoid reticulosis: a γδ T cell lymphoma? Eur J Dermatol. 1992;26:225. [Google Scholar]
- 5. Jones D, Vega F, Sarris AH, Medeiros LJ. CD4–CD8–‘‘double-negative’’ cutaneous T-cell lymphomas share common histologic features and an aggressive clinical course. Am J Surg Pathol. 2002;26(2):225–31. [DOI] [PubMed] [Google Scholar]
- 6. Hodak E, David M, Maron L, Aviram A, Kaganovsky E, Feinmesser M. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides. J Am Acad Dermatol. 2006;55(2):276–84. [DOI] [PubMed] [Google Scholar]
- 7. Lee J, Viakhireva N, Cesca C, Lee P, Kohler S, Hoppe RT, et al. Clinicopathologic features and treatment outcomes in Woringer-Kolopp disease. J Am Acad Dermatol. 2008;59(4):706–12. [DOI] [PubMed] [Google Scholar]
- 8. Wood GS, Weiss LM, Hu CH, Abel EA, Hoppe RT, Warnke RA, et al. T-cell antigen deficiencies and clonal rearrangements of T-cell receptor genes in pagetoid reticulosis (Woringer-Kolopp disease). N Engl J Med. 1988;318(3):164–7. [DOI] [PubMed] [Google Scholar]
- 9. Zengin AY, Topkan E, Cimsit G, Yildiz K. Woringer-Kolopp disease coexpressing CD4 and CD8 treated with radiation therapy: a case report. Tumori. 2008;94(5):754–7. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data supporting this case report are published online and available for reference. Further inquiries can be directed to the corresponding author, Dr. Ghassan Niaz.
